Abstract Details

Title Pregnancy outcomes with interferons or glatiramer acetate exposure in Multiple Sclerosis

Topic Multiple Sclerosis

Presentation(s) P1 - (-)

Poster/Presentation
Number 360

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Nigar Dargah-Zada, MD (Complete Neurological Care) PRESENTER	Dr. Dargah-Zada has nothing to disclose.
Cynthia L. Harden, MD (Xenon Pharmaceuticals Inc)	Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.

��ɫ����